'Encouraged by strong performance', says Kiran Mazumdar-Shaw on Biocon Q4 results

Biocon reported a 4 per cent decline in consolidated net profit to Rs 283.9 crore in the quarter ending March 31, 2022. 

Related Keywords

Kiran Mazumdar Shaw ,Biocon Biologics ,Serum Institute Life Sciences ,Biocon ,Biocon Executive Chairperson Kiran Mazumdar Shaw ,Kiran Mazumdar Shaw Tweet ,Iran Mazumdar Shaw Latest Tweet ,Iran Mazumdar Shaw On Biocon Q4 ,Iocon Q4 ,Biocon Q4 Results ,Iocon Q4 Result ,Iocon Q4 Profit ,Iocon Q4 Revenue ,Iocon Q4 Dividend ,Iocon Q4 Biosimilars Business ,Iocon Q4 Generics Business , ,